<?xml version="1.0" encoding="UTF-8"?>
<p>Patients infected with COVID-19 have a higher risk of dying when there are comorbidities such as diabetes, hypertension, obesity and other pathologies that comprised the MS. Furthermore, there is a higher mortality rate when there is cardiac injury associated to a viral infection as reported in previous studies ([
 <xref rid="B76-medicina-56-00386" ref-type="bibr">76</xref>] 
 <uri>ClinicalTrials.gov</uri>, Identifier NCT04291729). Therefore, even in an emergency, the mechanisms of action of each drug of the combinatorial therapy should be taken into account. The interactions and doses should also be considered for toxicity since, a greater adverse effect, if not born in mind, could be expected, which could be more dangerous than the disease itself.
</p>
